| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/11/2001 | CN1303287A Opioid agonist/antagonist combinations |
| 07/11/2001 | CN1303285A Microemulsion preconcentrates containing piperidine substance P antagonist |
| 07/11/2001 | CN1303284A 8-chloro-6,11-dihydro-11-(4-piperidylidene)-5H-benzo[5,6] cyclohepta [1,2-b] pyridine oral compositions |
| 07/11/2001 | CN1303280A Stable dosage forms of fluoxetine and its enantiomers |
| 07/11/2001 | CN1303278A Compositions containing microparticles of water-insoluble substances and method for their preparation |
| 07/11/2001 | CN1303277A Controlled release preparations having multi-layer structure |
| 07/11/2001 | CN1303276A Drug delivery system comprising tightly compacted solid medicament stock |
| 07/11/2001 | CN1303275A Polymer based rapidly dissolving tablets and production processes thereof |
| 07/11/2001 | CN1303274A Novel poly (methylidene malonate) microspheres, preparation method and pharmaceutical compositions containing them |
| 07/11/2001 | CN1303273A Use of particulate contrast agents in diagnostic imaging for studying physiological parameters |
| 07/11/2001 | CN1303272A Preparations for application of anti-inflammatory, especially antiseptic agents and/or agents promoting healing of wounds, to upper respiratory tract and/or ear |
| 07/11/2001 | CN1303271A Preparations for application of anti-inflammatory, especially antiseptic agents and/or agents promoting healing of wounds, to lower respiratory tract |
| 07/11/2001 | CN1303270A 气雾剂组合物 Aerosol composition |
| 07/11/2001 | CN1303269A Anticancer compositions |
| 07/11/2001 | CN1303263A Topital delivery system for active agents |
| 07/11/2001 | CN1303260A Alpha-hydroxy fatty acid derivatives and composition for external use containing same |
| 07/11/2001 | CN1302663A Substrate tablet containing trimetazidine capable of long time controlled release after oral application |
| 07/11/2001 | CN1302650A 'Hehe' ointment and its preparing process |
| 07/11/2001 | CN1302647A Medical capsule for treating hepatitis and its preparing process |
| 07/11/2001 | CN1302646A Exterior-applied ointment for lossing weight and its preparing process |
| 07/11/2001 | CN1302645A Medical capsule for invigorating function of spleen and its preparing process |
| 07/11/2001 | CN1302644A Hemostatic capsule and its preparing process |
| 07/11/2001 | CN1302636A 'Yishentongbi' pill for treating hyperosteogeny and its preparing process |
| 07/11/2001 | CN1302629A Buccal lozenge of notoginseng flower |
| 07/11/2001 | CN1302628A Hard capsule of superfine notoginseng powder |
| 07/11/2001 | CN1302625A Buccal lozenge of superfine notoginseng powder |
| 07/11/2001 | CN1302622A Moxaburning medicine as Chinese patent one for treating cancer |
| 07/11/2001 | CN1302608A Clonidine preparation |
| 07/11/2001 | CN1302607A Slow-releasing magnesium propylvalerate tablet and its preparing process |
| 07/11/2001 | CN1302606A Method of preparing water soluble film |
| 07/11/2001 | CN1302605A Controlled releasing oral medicine composition |
| 07/11/2001 | CN1302604A Controlled release composition |
| 07/11/2001 | CN1302603A Process for preparing adjustable release-controlled preparation |
| 07/11/2001 | CN1302559A Curcumin preparation |
| 07/11/2001 | CN1068305C Process for preparing S(-)-2-(4-isobutyl-phenyl) with antimer of purity more than 90% |
| 07/11/2001 | CN1068230C Phase shift colloids as ultrasound contrast agents |
| 07/11/2001 | CN1068227C Interferon liposome jellies |
| 07/11/2001 | CN1068226C Venereal disease preventing medicine containing interferon |
| 07/11/2001 | CN1068224C External protection medicine for preventing schistosoma miracidium infection |
| 07/11/2001 | CN1068221C Capsule for treating gonorrhea and preparation method |
| 07/11/2001 | CN1068220C Medicine for treating cervical erosion and method for preparing same |
| 07/11/2001 | CN1068219C Slow-released analgesic suppository and its preparation process |
| 07/11/2001 | CN1068218C Plaster for curing prolapse of lumbar intervertebral disk |
| 07/11/2001 | CN1068215C Pasting preparation for eliminating pain |
| 07/11/2001 | CN1068214C Luxian oral liquid and its preparation method |
| 07/11/2001 | CN1068210C Monkshood polysaccharide injection and preparing process thereof |
| 07/11/2001 | CN1068209C Chinese patent medicine for curing tuberculosis of lung and preparation process thereof |
| 07/11/2001 | CN1068207C Cap for preventing and curing cerebral hemorrhage |
| 07/11/2001 | CN1068199C Anti-cancer microballs and manufacturing method thereof |
| 07/11/2001 | CN1068198C Production method of composite preparation of bone morphogenesis protein and collagen particle |
| 07/10/2001 | WO2001051056A1 Fulvestrant formulation |
| 07/10/2001 | US6258995 Wound treatment composition |
| 07/10/2001 | US6258870 Gels for encapsulation of biological materials |
| 07/10/2001 | US6258857 Internal liquid composition contained as internal liquid in a releasing container and releasing container product |
| 07/10/2001 | US6258856 Administering estrogen for cataract prevention |
| 07/10/2001 | US6258855 Method of retarding and ameliorating carpal tunnel syndrome |
| 07/10/2001 | US6258849 Treatment regimen for administration of phenylacetylglutamine, phenylacetylisoglutamine, and/or phenylacetate |
| 07/10/2001 | US6258846 Enriching breast milk |
| 07/10/2001 | US6258831 Viral treatment |
| 07/10/2001 | US6258830 Skin disorders, psoriasis and acne |
| 07/10/2001 | US6258821 Compositions comprising trimetrexate and methods of their synthesis and use |
| 07/10/2001 | US6258816 Anti-allergy anti-inflammatory composition |
| 07/10/2001 | US6258814 Intranasal administering as sedatives |
| 07/10/2001 | US6258808 Pharmaceutical composition |
| 07/10/2001 | US6258799 Hydroxypropylmethyl cellulose trimelliate and plasticizers |
| 07/10/2001 | US6258797 Combating infection in delivery systems |
| 07/10/2001 | US6258783 Cyclosporins dissolved in solvent concentrate or microemulsion preconcentrate which comprise a cyclosporin as active ingredient, acetylated monoglyceride as lipophilic solvent, a surfactant, and optionally a hydrophilic solvent. |
| 07/10/2001 | US6258600 Antisense modulation of caspase 8 expression |
| 07/10/2001 | US6258385 Tetrasilver tetroxide treatment for skin conditions |
| 07/10/2001 | US6258384 Frozen product and method of oral delivery of active ingredients |
| 07/10/2001 | US6258381 Tablet and process for making the same |
| 07/10/2001 | US6258380 Flexible gelatin sheath of different blooms; plasticizer, moisturizer |
| 07/10/2001 | US6258378 Delivery of biologically active substance to target sites in the body of patients |
| 07/10/2001 | US6258377 Hydrophobic preparations containing medium chain monoglycerides |
| 07/10/2001 | US6258376 Treating helicobacter infections and gastrointestinal disorders; antiulcer agents |
| 07/10/2001 | US6258375 Oral nutrient prevents adhesion of haemophilus influenzae to nasopharyngeal cells |
| 07/10/2001 | US6258374 Rectal or vaginal administration; polymer stabilizer; water soluble foam structure |
| 07/10/2001 | US6258372 Xylitol nose spray |
| 07/10/2001 | US6258365 Organosilicone gel compositions for personal care |
| 07/10/2001 | US6258350 Topically, sustained-release, non-stinging administratable comprising beta blocker basic active, polyanionic polymer and divinylbenzene-styrene cation exchange resin; glaucoma therapy |
| 07/10/2001 | US6258341 Drug dispersion for oral inhalation and pulmonary absorption |
| 07/10/2001 | US6258338 Comprising beta-emitting radionuclide of yttria used in internal radiation therapy of cancer and tumors of the liver |
| 07/10/2001 | US6258297 Comprising active ingredient in the form of a hydrophobic liquid; for use in food, cosmetic and paint industries; storage stability |
| 07/10/2001 | US6258121 Stent coating |
| 07/10/2001 | US6257512 Magnetized pre-wound sideless bobbins |
| 07/10/2001 | CA2076527C A process for the production of solid forms of active substances and the products obtained in this way |
| 07/05/2001 | WO2001048233A1 Viral core protein-cationic lipid-nucleic acid-delivery complexes |
| 07/05/2001 | WO2001048231A2 Method of achieving persistent transgene expression |
| 07/05/2001 | WO2001048117A1 Dry compositions containing hydrophobic amino acid |
| 07/05/2001 | WO2001048025A1 Cyclodextrins covalently bound to polysaccharides |
| 07/05/2001 | WO2001048024A1 Stabilized cyclodextrin complexes |
| 07/05/2001 | WO2001047943A1 Antisense modulation of akt-3 expression |
| 07/05/2001 | WO2001047913A2 Substituted n-benzyl-indol-3-yl glyoxylic acid derivatives having an anti-tumoral effect |
| 07/05/2001 | WO2001047595A1 Osmotic beneficial agent delivery system |
| 07/05/2001 | WO2001047563A1 Use of lithium (li+) for the preparation of a composition for transfection of a polynucleotide into a cell and compositions useful in gene therapy |
| 07/05/2001 | WO2001047562A2 Hydrolytically degradable carbamate derivatives of poly(ethylene glycol) |
| 07/05/2001 | WO2001047560A2 Particulate vitamin composition |
| 07/05/2001 | WO2001047559A1 Patches for external use |
| 07/05/2001 | WO2001047557A1 Oral preparations for diabetes |
| 07/05/2001 | WO2001047556A1 Composition promoting lacrimal secretion |